LEE'S PHARM: Voluntary Announcement - The First Patient in Hong Kong Receives AU409, a Novel Drug Product Manufactured by Zhaoke Guangzhou, in a Phase I Liver Cancer Clinical Trial

HKEX · Aug 1 21:35

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.